DNA vaccine for promoting regeneration and functional rehabilitation of nerves of central system

A DNA vaccine and nerve regeneration technology, applied in the field of medicine, can solve problems such as unsatisfactory, unsuitable for human beings, and unable to block inhibitory molecules

Inactive Publication Date: 2010-06-02
SOUTHERN MEDICAL UNIVERSITY
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the use of IN-1 to block Nogo-A is an attractive approach, there are many other inhibitory components in myelin, and IN-1 cannot block other numerous inhibitory molecules;
[0005] 2. Purified myelin was used as an immunogen for immunization; some scholars used purified myelin to immunize rats and successfully blocked all inhibitory factors. However, this method must use Freund’s incomplete adjuvant, which is not applicable to humans, and Potential risk of inducing a widespread autoimmune response;
[0006] 3. Construct a DNA vaccine against

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • DNA vaccine for promoting regeneration and functional rehabilitation of nerves of central system
  • DNA vaccine for promoting regeneration and functional rehabilitation of nerves of central system
  • DNA vaccine for promoting regeneration and functional rehabilitation of nerves of central system

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0028] In order to better understand the present invention, the preparation process of the DNA vaccine of the present invention and its technical effects will be described in detail below through specific examples.

[0029] 1. Reagents required for DNA vaccine construction and identification of the present invention

[0030]The LINGO-1 gene was purchased from Openbiosystem Company (Catalog Number: MHS1010-73556, and the vector was pCMV-SPORT6); the TN-R and neurocan domains were synthesized from the whole gene of Shanghai Invitrogen Company and connected to the pMD-18T vector, and the designed specificity The primers are also synthesized by the company (because the fragments are not long, in order to save time and prevent unnecessary base mutations when routinely catching genes, we use the whole gene synthesis method);

[0031] PCR Amplification Kit, DNA Marker (DL 2000, DL15000), Protein Marker and DAB Chromogenic Substrate were purchased from TaKaRa Company; PCR Purification...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Depthaaaaaaaaaa
Login to view more

Abstract

The invention provides a DNA vaccine for promoting regeneration and functional rehabilitation of nerves of a central system. The vaccine consists of antigen genes and eukaryon expression vectors, wherein the antigen genes are fusion genes which are formed by linearly connecting gene fragments in the LRR structure field of the coding LINGO-1, gene fragments in the EGFL structure field of the coding TN-R and gene fragments of the 1011st to the 1271st amino acid of the coding neurocan in sequence; and two of the gene fragments are connected by the DNA sequences coding three alanine. The DNA vaccine can express the fusion genes of the LRR structure field of the LINGO-1, the EGFL structure field of the TN-R and the 1011st to the 1271st amino acid of the neurocan, stimulate the human body to generate various antibodies of the nerve regeneration inhibiting factor, resist the activity of the axon growth inhibiting factor, and provide a good microenvironment for the regeneration and the functional rehabilitation of the nerves of the central system.

Description

technical field [0001] The present invention relates to the field of medicine, in particular to medical preparations, especially medical preparations containing antigens. Background technique [0002] Nerve regeneration and repair after central nervous system (Central Nervous System, CNS) injury is a very complex pathophysiological process, involving changes at all levels from molecules, cells, organs to the whole. The current research shows that the axon of the central nervous system is not lack of regenerative ability, but the internal environment of the central nervous system is not suitable for regeneration. In the early stage of CNS injury, the damaged and disintegrated myelin sheath (formed by oligodendrocytes) releases a large number of myelin-associated axon growth inhibitors, such as Nogo-A and myelin-associated glycoprotein (MAG) , oligodendrocyte myelin glycoprotein (oligodendrocyte-myelinglycoprotein, OMgp), etc. [0003] The current methods of counteracting th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K39/00A61K48/00A61P25/00C12N15/85
Inventor 徐如祥吕俊姜晓丹柯以铨张世忠段传志王清华
Owner SOUTHERN MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products